Peptide ChooserTirzepatide
FDA approvedPrescriptionChecked 2 Nov 2026
FDA approved: an FDA-approved product exists. FDA source, 19 Oct 2026. Our weight loss page lists it. The lowest monthly plan that is not compounded, at the online clinics we track, is $299 (Alloy, Zepbound KwikPen), checked 2 Nov 2026.
Evidence by goal
What each goal page that lists it says, word for word, with its sources. The evidence rating comes from a goal page's checked options table; a goal without one shows "Not rated".
| Goal | Evidence in people | What the goal page says |
|---|---|---|
| Weight lossTirzepatide (Zepbound) | Not rated | A weekly shot, same idea, larger average loss in trials. |
Online clinic prices
10 plans at the online clinics we track, cheapest first.
| Clinic | Plan | What it is | Per month | FDA letter | Online clinic |
|---|---|---|---|---|---|
| Mochi Health | Compounded Tirzepatide | Compounded | $90care fee not known | none | Online clinicNo paid link yet |
| Alloy | Compounded Tirzepatide | Compounded | $100+ $99/mo care | none | Online clinicNo paid link yet |
| Good Life Meds | Compounded Tirzepatide | Compounded | $129care fee not known | none | Online clinicNo paid link yet |
| Fifty 410 | Compounded Tirzepatide 8-Week Program | Compounded | $149.50all-in | FDA letter 20 Feb 2026 | Online clinicNo paid link yet |
| Fifty 410 | Compounded Tirzepatide | Compounded | $199all-in | FDA letter 20 Feb 2026 | Online clinicNo paid link yet |
| Zappy Health | Compounded Tirzepatide | Compounded | $279all-in | FDA letter 20 Feb 2026 | Online clinicNo paid link yet |
| Alloy | Zepbound KwikPen | Brand | $299+ $99/mo care | none | Online clinicNo paid link yet |
| Sesame | Zepbound KwikPen | Brand | $299+ $99/mo care | none | Online clinicNo paid link yet |
| Sesame | Zepbound Vial | Brand | $299+ $99/mo care | none | Online clinicNo paid link yet |
| Direct Meds | Compounded Tirzepatide | Compounded | $399all-in | FDA letter 9 Sep 2025 | Online clinicNo paid link yet |
Prices are the clinics' published monthly prices on 2 Nov 2026; "from" prices are the lowest shown. A clinic with an FDA warning letter is still listed; the letter is public record.
FDA warning letters
Our letters list is by company, not by substance. The letters page lists all 172, each with its subject and a link to fda.gov; filter it by a company name.
Compared with: Semaglutide vs Tirzepatide
Sources
- FDA, status of Tirzepatide, 19 Oct 2026: https://api.fda.gov/drug/drugsfda.json?search=products.active_ingredients.name%3A%22Tirzepatide%22&limit=100